Bath Savings Trust Co Boosts Stake in Eli Lilly

Investment firm increases holding in pharmaceutical giant by 16.8%

Mar. 27, 2026 at 7:35am

Got story updates? Submit your updates here. ›

Bath Savings Trust Co, an investment firm based in Maine, has increased its stake in Eli Lilly and Company by 16.8% in the fourth quarter of 2025. The firm now owns 24,423 shares of the pharmaceutical company's stock, valued at $26.2 million as of the most recent SEC filing.

Why it matters

Eli Lilly is one of the world's largest pharmaceutical companies, known for developing innovative drugs and treatments. The increase in Bath Savings Trust Co's stake suggests the firm sees long-term growth potential in Lilly's business and pipeline.

The details

Bath Savings Trust Co added 3,521 shares of Eli Lilly to its portfolio during the fourth quarter, bringing its total holding to 24,423 shares. The investment firm's stake in Lilly now accounts for about 2.6% of its total investment portfolio.

  • Bath Savings Trust Co increased its Eli Lilly stake in the 4th quarter of 2025.

The players

Bath Savings Trust Co

An investment firm based in Maine that manages a portfolio of stocks and other assets.

Eli Lilly and Company

A global pharmaceutical company headquartered in Indianapolis, Indiana that develops and commercializes a broad range of medicines and therapies.

Got photos? Submit your photos here. ›

The takeaway

The increase in Bath Savings Trust Co's stake in Eli Lilly suggests the investment firm sees long-term growth potential in the pharmaceutical company's business and pipeline of new drugs and treatments.